# Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

> **NCT00015886** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** fluorouracil

## Key facts

- **NCT ID:** NCT00015886
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01
- **Primary completion:** 2002-05
- **Final completion:** 2009-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015886, "Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00015886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*